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INTRODUCTION
Clinical trials leading to drug approval (registra-
tion trials) play a central role in the drug devel-
opment process, and clinical trials in the general
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Abstract : Clinical trials leading to drug approval (registration trials) play a central role in
the drug development process. Since the introduction of the Good Clinical Practice (GCP)
standard in 1997, the Japanese infrastructure for registration trials has improved. The
contribution of support staff, including clinical research coordinators (CRCs), to clinical
trials is now widely recognized in Japan. Quality issues and career development for these
support staff are being increasingly emphasized. The Shikoku Collaborative Group for
Promotion of Clinical Trials was organized in 2008 to address these issues through commu-
nication with the personnel involved in clinical trials in regional areas of Japan. To under-
stand the views and present status of personnel involved in clinical trials, we used ques-
tionnaires to survey the participants of the First Symposium of the Shikoku Collaborative
Group for Promotion of Clinical Trials held in August 2009. Group discussions and special
lectures occurred at the symposium. The questionnaire began with questions about basic
patient characteristics, followed by practical questions. Of 110 participants, there were 68
respondents (62%), including clinical trial support staff (clinical research coordinators
[n=36, 53%], administrative officers [n=9, 13%]), and medical staff [n=23, 34%]). Among the
support staff, 36 (80%) had more than 5 years of experience. The most common question-
naire answer selected for participation in the symposiumwas “willing to contact staff from
other medical institutions or organizations” for support staff and “to obtain further knowl-
edge concerning clinical trials” for medical staff. The overall view of the discussion (“Was
the discussion satisfactory?”) was favorable for 36 (53%) respondents. This survey revealed
that the group discussion in the present symposium appears to be valuable for partici-
pants, using overall satisfaction as a surrogate. Based on the information obtained in the
present study, further development of the clinical trial infrastructure, including training
opportunities and career development for support staff, is required. Due to the limitations
of this study, further analysis is warranted to determine the optimal strategy for train-
ing support staff. J. Med. Invest. 58 : 81-85, February, 2011
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practice setting are important for providing evidence
about the efficacy and safety of different agents in
various settings. Since the introduction of the Good
Clinical Practice (GCP) standard in 1997 and the
plan for the promotion of registration trials by the
Ministry of Health, Labor and Welfare and the Min-
istry of Culture and Science of Japan, the Japanese
infrastructure for registration trials has improved.
For example, the contribution of clinical research
coordinators (CRCs) to clinical trials is now widely
recognized. Recently, a marked increase both in the
absolute numbers and in the percentage of clinical
trial notifications of global clinical trials that include
Japanese subjects has been observed (1), and con-
ducting clinical trials has become increasingly com-
plicated in Japan as well as in the global settings
(2). Quality issues regarding support staff, in addi-
tion to investigators, are now being emphasized to
ensure celerity and high quality in clinical trial con-
duct.
To address clinical trial support staff quality is-
sues, various certification systems have been devel-
oped by societies, such as the CRC certification by
the Japanese Society for Clinical Pharmacology and
Therapeutics, and nationwide opportunities for learn-
ing and training have also been developed. In addi-
tion, person-to-person communication and discus-
sion of issues, including support staff quality is-
sues, appears to be a reasonable strategy for pro-
moting clinical trials among personnel involved in
clinical trials in regional areas. For this purpose, the
Shikoku Collaborative Group for Clinical Trials was
organized in 2008 by the personnel of departments
concerned with promotion of clinical trials in the
four university hospitals in the Shikoku area of
Japan. Since understanding the view and present
status of personnel involved in clinical trials may
contribute to future activity of the group, we used
questionnaires to survey the participants of the First
Symposium of the Shikoku Collaborative Group for
Clinical Trials held in August 2009 at Tokushima
University Hospital. Herein we present the results
of this analysis.
METHODS
The symposium was open to medical staff, con-
tract research organization staff, and site manage-
ment organization staff, and consisted of two parts.
The first part involved group discussions about is-
sues facing clinical trial management, such as basic
activity of CRCs, promotion of clinical trial enroll-
ment, multi-national clinical trials, CRC career paths,
and the administrative work involved in clinical tri-
als. The participants discussed each of these issues
for approximately 1.5 hours in small groups (n=8-
12). The second part consisted of special lectures
presented by clinical trial experts. After the sympo-
sium, a questionnaire was given to each participant.
The questionnaire began with questions about basic
participant characteristics. This was followed by
practical questions about issues such as the main
reason for participating in the symposium and views
on present training opportunities using a five-point
scale (strongly agree, agree, neutral, disagree, and
strongly disagree).
We compared the views of clinical trial support
staff (CRCs and administrative officers) with those
of medical staff, and categorical variables were ana-
lyzed using the χ2 test. P values0.05 were con-
sidered to be statistically significant. All P values
were based on two-sided tests.
RESULTS
Respondent characteristics
Of 110 symposium participants, 68 questionnaire
respondents (62%) were included in this analysis.
These respondents included CRCs (n=36, 53%),
administrative officers (n=9, 13%), and medical
staff (physicians, n=3, 4% ; pharmacists, n=16, 24% ;
nurses, n=3, 4% ; and a clinical laboratory techni-
cian, n=1, 2%).
Among the clinical trial support staff (CRCs and
administrative officers, n=45), 36 (80%) had more
than 5 years of experience, whereas 9 (20%) had
less than 1 year of experience. With respect to pre-
vious experience with small-group clinical trial train-
ing, 17 respondents had never participated in small-
group training (38%), 9 had participated in small-
group training one time (20%), 9 had participated
in it two times (20%), and 3 had participated in it
more than two times (7%) ; 7 participants provided
no answer.
Certification of CRC respondents
Only 7 (19%) of the responding CRCs (n=36) had
already acquired certification by the Japanese So-
ciety for Clinical Pharmacology and Therapeutics,
while 5 expressed their willingness for future ac-
quisition of this certification.
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Main reason for participating in the symposium
Select answers to the survey questions are shown
in Table 1. The main reasons for participation were
as follows : willing to attend the first such sympo-
sium in the Shikoku district (n=17, 25%), willing to
contact staff from other medical institutions or or-
ganizations (n=16, 24%), to obtain further knowl-
edge concerning clinical trials (n=30, 44%), and
other (n=5, 7%). The “willing to contact staff from
other medical institutions or organizations” answer
was observed at a significantly higher frequency
(P=0.008) in support staff (n=15, 33%) compared
to medical staff (n=1, 4.3%), whereas the “to obtain
further knowledge concerning clinical trials” re-
sponse was observed at a significantly higher fre-
quency (P=0.012) in medical staff (n=15, 65%) com-
pared to support staff (n=15, 33%).
View of the training method itself
As noted above, each participant discussed each
issue for about 1.5 hours in small groups (n=8-2).
A considerable number of respondents (27 [40%])
wanted to participate in discussions in groups con-
sisting of fewer individuals (8), and 43 (63%)
wished to hold the discussions for a longer period
of time. The discussions were open to medical staff,
contract research organization staff, and site man-
agement organization staff. The majority of respon-
dents (44, 65%) agreed that participation from spon-
sors, such as pharmaceutical companies, would be
welcomed.
The overall views of the discussion (“Was the dis-
cussion satisfactory?”) were as follows : strongly
agree (12 [18%]), agree (24 [35%]), neutral (12
[18%]), disagree (3 [4%]), and strongly disagree (1
[2%]) ; 16 (24%) respondents provided no answer.
DISCUSSION
Before the introduction of the CRC concept, in-
vestigators participating in Japanese registration tri-
als performed virtually all tasks related to the trial,
from patient care to administrative work, through-
out the course of the study (3). The importance of
the contribution of CRCs to clinical trials is now
widely recognized, even in Japan. In our previous
study conducted at the Tokushima University Hospi-
tal, over 80% of the doctors requested CRC support
throughout the registration trial (4). In addition, we
found that physicians who could recruit participants
into a trial considered the presence of a support sys-
tem with CRCs as the reason to participate in the
trial (5).
In the global setting, Gets et al . (2) at the Tufts
Center for the Study of Drug Development analyzed
data on protocols and study conduct performance
in clinical trials conducted between 1999 and 2005.
These investigators reported that the number of
unique procedures and the frequency of procedures
per protocol had increased, and investigative site
work burden to administer each protocol increased
at an even faster rate. Additionally, study conduct
performance-that is, cycle time and patient recruit-
ment and retention rates-worsened. In Japan, a
marked increase both in the absolute numbers
and in the percentage of clinical trial notifications
of global clinical trials that include Japanese sub-
jects has occurred in recent years (1). While cancer
and cardiovascular disease have been the major
target diseases of these trials, the range has re-
cently expanded to include other diseases.
In consideration of these circumstances, improv-
ing the skills of clinical trial support staff, such as
CRCs and administrative staff, in addition to those
Table 1 Main reason for participating in the symposium
Total (n=68) Support staff (n=45) Medical staff (n=23)
Willing to attend the first such symposium in the Shikoku district 17 (25.0%) 13 (28.9%) 4 (17.4%)
Willing to contact staff from other medical institutions or organizations 16 (23.5%) 15 (33.3%)* 1 (4.3%)
To obtain further knowledge concerning clinical trials 30 (44.1%) 15 (33.3%) 15 (65.2%)**
Other 5 (7.4%) 2 (4.4%) 3 (13.0%)
* Significantly different (P=0.008) than medical staff
** Significantly different (P=0.012) than support staff
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of the investigators, is now being emphasized at
each medical institution to ensure efficient progress
and improved quality of clinical trials. Moreover,
support staff-specific issues, such as CRC career de-
velopment, are now also identified as being impor-
tant. The Shikoku Collaborative Group for Clinical
Trials was organized in 2008 to fulfill these demands
in the Shikoku area in Japan, and we conducted
the present analysis to promote activity of the group
by understanding the views and present status of
the personnel involved in clinical trials.
To improve the skills of CRCs in Japan, obtain-
ing and maintaining certification by the Japanese
Society for Clinical Pharmacology and Therapeu-
tics would appear to be desirable. However, in the
present survey, few CRCs had already acquired or
expressed their willingness for future acquisition of
this certification. The possibility that regional dif-
ferences, such as a relatively smaller number of
clinical trials conducted in regional areas compared
to urban areas, could result in the “less” require-
ment for skilled CRCs should be considered. In the
group discussions about CRC career development,
many CRCs insisted that there is little incentive to
becoming a CRC and that no organized career path
for CRCs exists (data not shown). Development of
a clear CRC career path is an important issue for
this collaborative group to resolve.
Regarding the reason for participating in the pre-
sent symposium, more supportive staff than medical
staff showed their willingness to contact staff from
other medical institutions or organizations. From
the perspective of the CRC, medical staffs, such as
ward-based clinical nurses work as a nursing team.
On the other hand, CRCs must be able to compe-
tently perform their research roles and must adapt
to working alone and working with a variety of
clinical professionals. CRCs often feel insecure and
feel that they are perceived as a minority group,
and that their complaints cannot be accepted by
their colleagues who lack understanding and insight
into the research process (6). Feelings of isolation
and tension throughout clinical trials exist, even
after CRCs have gained skills and confidence in
their roles (7). Although it is now widely accepted
that CRCs play important roles in ensuring the
quality of clinical trials while lessening the work-
load of physicians, networking of CRCs, such as in
the present collaborative group, could be beneficial
for the support staff, including CRCs, to lessen
their feelings of isolation, and may contribute to
more efficient job performance.
Various methods exist for training medical staff,
including CRCs. Compared to self-study, investiga-
tor meetings, and lectures, small-group discussions
have unique value in their interactivity and imme-
diate feedback. In the present analysis, discussions
of approximately 1.5 hours in length in small groups
(n=8-12) appeared to be unsatisfactory to the par-
ticipants. Longer discussion periods with participa-
tion of various professionals, including monitors and
audit-related individuals from sponsors, such as
pharmaceutical companies, should be considered
for future small-group discussions. Taekman et al .
(8) published a preliminary report on the use of
high-fidelity simulation in the training of study co-
ordinators conducting a clinical research protocol.
Improvement of training methodology and evalu-
ation of the contribution of training to clinical trial
quality should be considered as a future goal of this
collaborative group.
The present study evaluated only a small number
of professionals involved in clinical trials. Neverthe-
less, the group discussion format used in the pre-
sent symposium appears to be of value to partici-
pants when overall satisfaction is used as a surro-
gate. It is necessary to develop the proper infrastruc-
ture, including training opportunities, in the Shikoku
area, based on the information obtained in the pre-
sent study. Because of the study limitations, further
study is warranted to determine the generalizability
of the present findings to other Japanese regional
areas.
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